Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
AstraZeneca
Express Scripts
McKesson
Medtronic
Merck

Last Updated: January 19, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for GSK2982772


Email this page to a colleague

« Back to Dashboard

What is the drug development status for GSK2982772?

GSK2982772 is an investigational drug.

There have been 9 clinical trials for GSK2982772. The most recent clinical trial was a Phase 2 trial, which was initiated on November 15th 2016.

The most common disease conditions in clinical trials are Autoimmune Diseases, Psoriasis, and Colitis, Ulcerative. The leading clinical trial sponsors are GlaxoSmithKline, Quotient Clinical, and Quotient Sciences.

There are ten US patents protecting this investigational drug and one hundred and thirty-eight international patents.

Recent Clinical Trials for GSK2982772
TitleSponsorPhase
A Study to Evaluate the Benefit and Safety of GSK2982772 in Moderate to Severe Psoriasis ParticipantsGlaxoSmithKlinePhase 1
A Study to Investigate the Pharmacokinetics (PK) of Modified Release (MR) Prototype Coated Tablet Formulations of GSK2982772Quotient SciencesPhase 1
A Study to Investigate the Pharmacokinetics (PK) of Modified Release (MR) Prototype Coated Tablet Formulations of GSK2982772GlaxoSmithKlinePhase 1

See all GSK2982772 clinical trials

Clinical Trial Summary for GSK2982772

Top disease conditions for GSK2982772
Top clinical trial sponsors for GSK2982772

See all GSK2982772 clinical trials

US Patents for GSK2982772

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
GSK2982772 ⤷  Try it Free Compounds, compositions and methods Denali Therapeutics Inc. (South San Francisco, CA) ⤷  Try it Free
GSK2982772 ⤷  Try it Free Crystalline forms of (S)-5-benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-- yl)-4H-1,2,4-triazole-3-carboxamide GlaxoSmithKline Intellectual Property Development Limited (Brentford, Middlesex, GB) ⤷  Try it Free
GSK2982772 ⤷  Try it Free Heterocyclic amides as kinase inhibitors GlaxoSmithKline Intellectual Property Development Limited (Brentford, Middlesex, GB) ⤷  Try it Free
GSK2982772 ⤷  Try it Free Compounds, compositions and methods Denali Therapeutics Inc. (South San Francisco, CA) ⤷  Try it Free
GSK2982772 ⤷  Try it Free Heterocyclic compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (Osaka-Shi, Osaka, JP) ⤷  Try it Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for GSK2982772

Drugname Country Document Number Estimated Expiration Related US Patent
GSK2982772 Argentina AR107537 2036-02-05 ⤷  Try it Free
GSK2982772 Argentina AR115780 2036-02-05 ⤷  Try it Free
GSK2982772 Australia AU2017213628 2036-02-05 ⤷  Try it Free
GSK2982772 Brazil BR112018015410 2036-02-05 ⤷  Try it Free
GSK2982772 Canada CA3012832 2036-02-05 ⤷  Try it Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
AstraZeneca
Express Scripts
McKesson
Medtronic
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.